More than two decades of Apc modeling in rodents

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1836, Issue 1, 2013, Pages 80-89

  Zeineldin, Maged ^a   Neufeld, Kristi L ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Adenomatous polyposis coli APC; Apc mouse model; Conditional Apc mutation; FAP model; Intestinal polyposis; LOH Apc mouse model

Indexed keywords

APC PROTEIN; APC1309 PROTEIN; APC1322T PROTEIN; APC1572T PROTEIN; APC1638N PROTEIN; APC1638T PROTEIN; ONCOPROTEIN; SMAD4 PROTEIN; UNCLASSIFIED DRUG;

ADENOMATOUS POLYPOSIS COLI GENE; ATP5A1 GENE; COLON POLYPOSIS; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; GENE DELETION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INTESTINE TUMOR; MOLECULAR PATHOLOGY; MULTIPLE INTESTINAL NEOPLASIA; MUTATOR GENE; NONHUMAN; PHENOTYPE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TRANSGENIC MOUSE; TUMOR MODEL;

ADENOMATOUS POLYPOSIS COLI; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; DISEASE MODELS, ANIMAL; GENOTYPE; HUMANS; MICE; PHENOTYPE; RATS;

EID: 84877109867     PISSN: 0304419X     EISSN: 18792561     Source Type: Journal    
DOI: 10.1016/j.bbcan.2013.01.001     Document Type: Review

References (135)

1. Joslyn G., Carlson M., Thliveris A., Albertsen H., Gelbert L., Samowitz W., Groden J., Stevens J., Spirio L., Robertson M., Sargeant L., Krapcho K., Wolff E., Burt R., Hughes J.P., Warrington J., McPherson J., Wasmuth J., Paslier D.L., Abderrahim H., Cohen D., Leppert M., White R. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 1991, 66:601-613.
2. Groden J., Thliveris A., Samowitz W., Carlson M., Gelbert L., Albertsen H., Joslyn G., Stevens J., Spirio L., Robertson M., Sargeant L., Krapcho K., Wolff E., Burt R., Hughes J.P., Warrington J., McPherson J., Wasmuth J., Paslier D.L., Abderrahim H., Cohen D., Leppert M., White R. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66:589-600.
3. Nishisho I., Nakamura Y., Miyoshi Y., Miki Y., Ando H., Horii A., Koyama K., Utsunomiya J., Baba S., Hedge P. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991, 253:665-669.
4. Kinzler K.W., Nilbert M.C., Su L.K., Vogelstein B., Bryan T.M., Levy D.B., Smith K.J., Preisinger A.C., Hedge P., McKechnie D., Finniear R., Markham A., Groffen J., Boguski M.S., Altschul S.F., Horii A., Ando H., Miyoshi Y., Miki Y., Nishisho I., Nakamura Y. Identification of FAP locus genes from chromosome 5q21. Science 1991, 253:661-665.
5. Kinzler K.W., Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996, 87:159-170.
6. TCGA Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487:330-337.
7. Polakis P. Wnt signaling and cancer. Genes Dev. 2000, 14:1837-1851.
8. Senda T., Iizuka-Kogo A., Onouchi T., Shimomura A. Adenomatous polyposis coli (APC) plays multiple roles in the intestinal and colorectal epithelia. Med. Mol. Morphol. 2007, 40:68-81.
9. Minde D.P., Anvarian Z., Rudiger S.G., Maurice M.M. Messing up disorder: how do missense mutations in the tumor suppressor protein APC lead to cancer?. Mol. Cancer 2011, 10:101.
10. Carbone L. What Animals Want: Expertise and Advocacy in Laboratory Animal Welfare Policy 2004, Oxford University Press, Cary, NC, USA.
11. Uronis J.M., Threadgill D.W. Murine models of colorectal cancer. Mamm. Genome 2009, 20:261-268.
12. Su L.K., Kinzler K.W., Vogelstein B., Preisinger A.C., Moser A.R., Luongo C., Gould K.A., Dove W.F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992, 256:668-670.
13. Gaspar C., Cardoso J., Franken P., Molenaar L., Morreau H., Moslein G., Sampson J., Boer J.M., de Menezes R.X., Fodde R. Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis. Am. J. Pathol. 2008, 172:1363-1380.
14. Moser A.R., Pitot H.C., Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990, 247:322-324.
15. Moser A.R., Dove W.F., Roth K.A., Gordon J.I. The Min (multiple intestinal neoplasia) mutation: its effect on gut epithelial cell differentiation and interaction with a modifier system. J. Cell Biol. 1992, 116:1517-1526.
16. Moser A.R., Mattes E.M., Dove W.F., Lindstrom M.J., Haag J.D., Gould M.N. ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:8977-8981.
17. McCart A.E., Vickaryous N.K., Silver A. Apc mice: models, modifiers and mutants. Pathol. Res. Pract. 2008, 204:479-490.
18. Shoemaker A.R., Moser A.R., Midgley C.A., Clipson L., Newton M.A., Dove W.F. A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:10826-10831.
19. Chen X., Halberg R.B., Burch R.P., Dove W.F. Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition. J. Mol. Histol. 2008, 39:283-294.
20. Halberg R.B., Waggoner J., Rasmussen K., White A., Clipson L., Prunuske A.J., Bacher J.W., Sullivan R., Washington M.K., Pitot H.C., Petrini J.H., Albertson D.G., Dove W.F. Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway. Cancer Res. 2009, 69:5768-5775.
21. Luongo C., Moser A.R., Gledhill S., Dove W.F. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res. 1994, 54:5947-5952.
22. Millar C.B., Guy J., Sansom O.J., Selfridge J., MacDougall E., Hendrich B., Keightley P.D., Bishop S.M., Clarke A.R., Bird A. Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 2002, 297:403-405.
23. Nakayama T., Yamazumi K., Uemura T., Yoshizaki A., Yakata Y., Matsuu-Matsuyama M., Shichijo K., Sekine I. X radiation up-regulates the occurrence and the multiplicity of invasive carcinomas in the intestinal tract of Apc(min/+) mice. Radiat. Res. 2007, 168:433-439.
24. Sieber O.M., Howarth K.M., Thirlwell C., Rowan A., Mandir N., Goodlad R.A., Gilkar A., Spencer-Dene B., Stamp G., Johnson V., Silver A., Yang H., Miller J.H., Ilyas M., Tomlinson I.P. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice. Cancer Res. 2004, 64:8876-8881.
25. Reichling T., Goss K.H., Carson D.J., Holdcraft R.W., Ley-Ebert C., Witte D., Aronow B.J., Groden J. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. Cancer Res. 2005, 65:166-176.
26. Will O.C., Leedham S.J., Elia G., Phillips R.K.S., Clark S.K., Tomlinson I.P.M. Location in the large bowel influences the APC mutations observed in FAP adenomas. Familial Cancer 2010, 9:389-393.
27. Haigis K.M., Caya J.G., Reichelderfer M., Dove W.F. Intestinal adenomas can develop with a stable karyotype and stable microsatellites. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:8927-8931.
28. Baran A.A., Silverman K.A., Zeskand J., Koratkar R., Palmer A., McCullen K., Curran W.J., Edmonston T.B., Siracusa L.D., Buchberg A.M. The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression. Genome Res. 2007, 17:566-576.
29. Imaoka T., Okamoto M., Nishimura M., Nishimura Y., Ootawara M., Kakinuma S., Tokairin Y., Shimada Y. Mammary tumorigenesis in ApcMin/+ mice is enhanced by X irradiation with a characteristic age dependence. Radiat. Res. 2006, 165:165-173.
30. Imbert A., Eelkema R., Jordan S., Feiner H., Cowin P. Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J. Cell Biol. 2001, 153:555-568.
31. Michaelson J.S., Leder P. Beta-catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene 2001, 20:5093-5099.
32. Half E., Bercovich D., Rozen P. Familial adenomatous polyposis. Orphanet J. Rare Dis. 2009, 4:22.
33. Jin Z., Tamura G., Tsuchiya T., Sakata K., Kashiwaba M., Osakabe M., Motoyama T. Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br. J. Cancer 2001, 85:69-73.
34. Sarrio D., Moreno-Bueno G., Hardisson D., Sanchez-Estevez C., Guo M., Herman J.G., Gamallo C., Esteller M., Palacios J. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int. J. Cancer 2003, 106:208-215.
35. Furuuchi K., Tada M., Yamada H., Kataoka A., Furuuchi N., Hamada J., Takahashi M., Todo S., Moriuchi T. Somatic mutations of the APC gene in primary breast cancers. Am. J. Pathol. 2000, 156:1997-2005.
36. 2-catenin pathway in invasive ductal carcinoma of breast. Life Sci. 2008, 83:318-325.
37. You S., Ohmori M., Pena M.M., Nassri B., Quiton J., Al-Assad Z.A., Liu L., Wood P.A., Berger S.H., Liu Z., Wyatt M.D., Price R.L., Berger F.G., Hrushesky W.J. Developmental abnormalities in multiple proliferative tissues of Apc(Min/+) mice. Int. J. Exp. Pathol. 2006, 87:227-236.
38. Chae W.J., Gibson T.F., Zelterman D., Hao L., Henegariu O., Bothwell A.L. Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:5540-5544.
39. Lane S.W., Sykes S.M., Al-Shahrour F., Shterental S., Paktinat M., Lo Celso C., Jesneck J.L., Ebert B.L., Williams D.A., Gilliland D.G. The Apc(min) mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS. Blood 2010, 115:3489-3497.
40. Coletta P.L., Muller A.M., Jones E.A., Muhl B., Holwell S., Clarke D., Meade J.L., Cook G.P., Hawcroft G., Ponchel F., Lam W.K., MacLennan K.A., Hull M.A., Bonifer C., Markham A.F. Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis. Blood 2004, 103:1050-1058.
41. Tanwar P.S., Zhang L., Teixeira J.M. Adenomatous polyposis coli (APC) is essential for maintaining the integrity of the seminiferous epithelium. Mol. Endocrinol. 2011, 25:1725-1739.
42. Prosperi J.R., Becher K.R., Willson T.A., Collins M.H., Witte D.P., Goss K.H. The APC tumor suppressor is required for epithelial integrity in the mouse mammary gland. J. Cell. Physiol. 2009, 220:319-331.
43. Lefebvre A.M., Chen I., Desreumaux P., Najib J., Fruchart J.C., Geboes K., Briggs M., Heyman R., Auwerx J. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat. Med. 1998, 4:1053-1057.
44. Girnun G.D., Smith W.M., Drori S., Sarraf P., Mueller E., Eng C., Nambiar P., Rosenberg D.W., Bronson R.T., Edelmann W., Kucherlapati R., Gonzalez F.J., Spiegelman B.M. APC-dependent suppression of colon carcinogenesis by PPARgamma. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:13771-13776.
45. Saez E., Tontonoz P., Nelson M.C., Alvarez J.G., Ming U.T., Baird S.M., Thomazy V.A., Evans R.M. Activators of the nuclear receptor PPARgamma enhance colon polyp formation. Nat. Med. 1998, 4:1058-1061.
46. Niho N., Mutoh M., Komiya M., Ohta T., Sugimura T., Wakabayashi K. Improvement of hyperlipidemia by indomethacin in Min mice. Int. J. Cancer 2007, 121:1665-1669.
47. Dove W.F., Cormier R.T., Gould K.A., Halberg R.B., Merritt A.J., Newton M.A., Shoemaker A.R. The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1998, 353:915-923.
48. Kwong L.N., Dove W.F. APC and its modifiers in colon cancer. Adv. Exp. Med. Biol. 2009, 656:85-106.
49. Silverman K.A., Koratkar R., Siracusa L.D., Buchberg A.M. Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. Genome Res. 2002, 12:88-97.
50. Kwong L.N., Shedlovsky A., Biehl B.S., Clipson L., Pasch C.A., Dove W.F. Identification of Mom7, a novel modifier of Apc(Min/+) on mouse chromosome 18. Genetics 2007, 176:1237-1244.
51. Suraweera N., Haines J., McCart A., Rogers P., Latchford A., Coster M., Polanco-Echeverry G., Guenther T., Wang J., Sieber O., Tomlinson I., Silver A. Genetic determinants modulate susceptibility to pregnancy-associated tumourigenesis in a recombinant line of Min mice. Hum. Mol. Genet. 2006, 15:3429-3435.
52. Crist R.C., Roth J.J., Lisanti M.P., Siracusa L.D., Buchberg A.M. Identification of Mom12 and Mom13, two novel modifier loci of Apc (Min)-mediated intestinal tumorigenesis. Cell Cycle 2011, 10:1092-1099.
53. MacPhee M., Chepenik K.P., Liddell R.A., Nelson K.K., Siracusa L.D., Buchberg A.M. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 1995, 81:957-966.
54. Cormier R.T., Hong K.H., Halberg R.B., Hawkins T.L., Richardson P., Mulherkar R., Dove W.F., Lander E.S. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat. Genet. 1997, 17:88-91.
55. Harris E.S., Nelson W.J. Adenomatous polyposis coli regulates endothelial cell migration independent of roles in beta-catenin signaling and cell-cell adhesion. Mol. Biol. Cell 2010, 21:2611-2623.
56. Munemitsu S., Souza B., Muller O., Albert I., Rubinfeld B., Polakis P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res. 1994, 54:3676-3681.
57. Radulescu S., Ridgway R.A., Appleton P., Kroboth K., Patel S., Woodgett J., Taylor S., Nathke I.S., Sansom O.J. Defining the role of APC in the mitotic spindle checkpoint in vivo: APC-deficient cells are resistant to Taxol. Oncogene 2010, 29:6418-6427.
58. Fodde R., Kuipers J., Rosenberg C., Smits R., Kielman M., Gaspar C., van Es J.H., Breukel C., Wiegant J., Giles R.H., Clevers H. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat. Cell Biol. 2001, 3:433-438.
59. Green R.A., Kaplan K.B. Chromosome instability in colorectal tumor cells is associated with defects in microtubule plus-end attachments caused by a dominant mutation in APC. J. Cell Biol. 2003, 163:949-961.
60. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature 1998, 396:643-649.
61. Kucherlapati M., Nguyen A., Kuraguchi M., Yang K., Fan K., Bronson R., Wei K., Lipkin M., Edelmann W., Kucherlapati R. Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies. Oncogene 2007, 26:6297-6306.
62. Bi X., Pohl N.M., Yin Z., Yang W. Loss of JNK2 increases intestinal tumor susceptibility in Apc1638+/- mice with dietary modulation. Carcinogenesis 2011, 32:584-588.
63. Nandan M.O., Ghaleb A.M., McConnell B.B., Patel N.V., Robine S., Yang V.W. Kruppel-like factor 5 is a crucial mediator of intestinal tumorigenesis in mice harboring combined ApcMin and KRASV12 mutations. Mol. Cancer 2010, 9:63.
64. Wilson A.J., Byun D.S., Popova N., Murray L.B., L'Italien K., Sowa Y., Arango D., Velcich A., Augenlicht L.H., Mariadason J.M. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J. Biol. Chem. 2006, 281:13548-13558.
65. Edelmann W., Yang K., Kuraguchi M., Heyer J., Lia M., Kneitz B., Fan K., Brown A.M., Lipkin M., Kucherlapati R. Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice. Cancer Res. 1999, 59:1301-1307.
66. Smits R., Kartheuser A., Jagmohan-Changur S., Leblanc V., Breukel C., de Vries A., van Kranen H., van Krieken J.H., Williamson S., Edelmann W., Kucherlapati R., Khan P.M., Fodde R. Loss of Apc and the entire chromosome 18 but absence of mutations at the Ras and Tp53 genes in intestinal tumors from Apc1638N, a mouse model for Apc-driven carcinogenesis. Carcinogenesis 1997, 18:321-327.
67. Haigis K.M., Hoff P.D., White A., Shoemaker A.R., Halberg R.B., Dove W.F. Tumor regionality in the mouse intestine reflects the mechanism of loss of Apc function. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:9769-9773.
68. Smits R., van der Houven W., van Oordt A., Luz C., Zurcher S., Jagmohan-Changur C., Breukel P.M., Khan R.Fodde Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts. Gastroenterology 1998, 114:275-283.
69. Lyons L.A., Lewis R.A., Strong L.C., Zuckerbrod S., Ferrell R.E. A genetic study of Gardner syndrome and congenital hypertrophy of the retinal pigment epithelium. Am. J. Hum. Genet. 1988, 42:290-296.
70. Nieuwenhuis M.H., Vasen H.F. Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature. Crit. Rev. Oncol. Hematol. 2007, 61:153-161.
71. Bisgaard M.L., Bulow S. Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts. Am. J. Med. Genet. A 2006, 140:200-204.
72. Crabtree M., Sieber O.M., Lipton L., Hodgson S.V., Lamlum H., Thomas H.J.W., Neale K., Phillips R.K.S., Heinimann K., Tomlinson I.P.M. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients. Oncogene 2003, 22:4257-4265.
73. Fodde R., Edelmann W., Yang K., van Leeuwen C., Carlson C., Renault B., Breukel C., Alt E., Lipkin M., Khan P.M., Kucherlapati R. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:8969-8973.
74. Smits R., Kielman M.F., Breukel C., Zurcher C., Neufeld K., Jagmohan-Changur S., Hofland N., van Dijk J., White R., Edelmann W., Kucherlapati R., Khan P.M., Fodde R. Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev. 1999, 13:1309-1321.
75. Yokoyama A., Nomura R., Kurosumi M., Shimomura A., Onouchi T., Iizuka-Kogo A., Smits R., Oda N., Fodde R., Itoh M., Senda T. The C-terminal domain of the adenomatous polyposis coli (Apc) protein is involved in thyroid morphogenesis and function. Med. Mol. Morphol. 2011, 44:207-212.
76. Gaspar C., Franken P., Molenaar L., Breukel C., van der Valk M., Smits R., Fodde R. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis. PLoS Genet. 2009, 5:e1000547.
77. Falk S., Wurdak H., Ittner L.M., Ille F., Sumara G., Schmid M.T., Draganova K., Lang K.S., Paratore C., Leveen P., Suter U., Karlsson S., Born W., Ricci R., Gotz M., Sommer L. Brain area-specific effect of TGF-beta signaling on Wnt-dependent neural stem cell expansion. Cell Stem Cell 2008, 2:472-483.
78. Alberici P., Jagmohan-Changur S., De Pater E., Van Der Valk M., Smits R., Hohenstein P., Fodde R. Smad4 haploinsufficiency in mouse models for intestinal cancer. Oncogene 2006, 25:1841-1851.
79. Lamlum H., Ilyas M., Rowan A., Clark S., Johnson V., Bell J., Frayling I., Efstathiou J., Pack K., Payne S., Roylance R., Gorman P., Sheer D., Neale K., Phillips R., Talbot I., Bodmer W., Tomlinson I. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat. Med. 1999, 5:1071-1075.
80. Albuquerque C., Breukel C., van der Luijt R., Fidalgo P., Lage P., Slors F.J., Leitao C.N., Fodde R., Smits R. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade. Hum. Mol. Genet. 2002, 11:1549-1560.
81. Lamlum H., Papadopoulou A., Ilyas M., Rowan A., Gillet C., Hanby A., Talbot I., Bodmer W., Tomlinson I. APC mutations are sufficient for the growth of early colorectal adenomas. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:2225-2228.
82. Pollard P., Deheragoda M., Segditsas S., Lewis A., Rowan A., Howarth K., Willis L., Nye E., McCart A., Mandir N., Silver A., Goodlad R., Stamp G., Cockman M., East P., Spencer-Dene B., Poulsom R., Wright N., Tomlinson I. The Apc 1322T mouse develops severe polyposis associated with submaximal nuclear beta-catenin expression. Gastroenterology 2009, 136:2204-2213. (e2201-2213).
83. Quesada C.F., Kimata H., Mori M., Nishimura M., Tsuneyoshi T., Baba S. Piroxicam and acarbose as chemopreventive agents for spontaneous intestinal adenomas in APC gene 1309 knockout mice. Jpn. J. Cancer Res. Gann. 1998, 89:392-396.
84. Lewis A., Segditsas S., Deheragoda M., Pollard P., Jeffery R., Nye E., Lockstone H., Davis H., Clark S., Stamp G., Poulsom R., Wright N., Tomlinson I. Severe polyposis in Apc(1322T) mice is associated with submaximal Wnt signalling and increased expression of the stem cell marker Lgr5. Gut 2010, 59:1680-1686.
85. Niho N., Takahashi M., Kitamura T., Shoji Y., Itoh M., Noda T., Sugimura T., Wakabayashi K. Concomitant suppression of hyperlipidemia and intestinal polyp formation in Apc-deficient mice by peroxisome proliferator-activated receptor ligands. Cancer Res. 2003, 63:6090-6095.
86. Crist R.C., Roth J.J., Baran A.A., McEntee B.J., Siracusa L.D., Buchberg A.M. The armadillo repeat domain of Apc suppresses intestinal tumorigenesis. Mamm. Genome 2010, 21:450-457.
87. Sasai H., Masaki M., Wakitani K. Suppression of polypogenesis in a new mouse strain with a truncated Apc(Delta474) by a novel COX-2 inhibitor, JTE-522. Carcinogenesis 2000, 21:953-958.
88. Oshima M., Oshima H., Kobayashi M., Tsutsumi M., Taketo M.M. Evidence against dominant negative mechanisms of intestinal polyp formation by Apc gene mutations. Cancer Res. 1995, 55:2719-2722.
89. Oshima M., Oshima H., Kitagawa K., Kobayashi M., Itakura C., Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:4482-4486.
90. Oshima H., Oshima M., Kobayashi M., Tsutsumi M., Taketo M.M. Morphological and molecular processes of polyp formation in Apc(delta716) knockout mice. Cancer Res. 1997, 57:1644-1649.
91. Kuraguchi M., Wang X.P., Bronson R.T., Rothenberg R., Ohene-Baah N.Y., Lund J.J., Kucherlapati M., Maas R.L., Kucherlapati R. Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. PLoS Genet. 2006, 2:e146.
92. Shibata H., Toyama K., Shioya H., Ito M., Hirota M., Hasegawa S., Matsumoto H., Takano H., Akiyama T., Toyoshima K., Kanamaru R., Kanegae Y., Saito I., Nakamura Y., Shiba K., Noda T. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 1997, 278:120-123.
93. Colnot S., Decaens T., Niwa-Kawakita M., Godard C., Hamard G., Kahn A., Giovannini M., Perret C. Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:17216-17221.
94. Robanus-Maandag E.C., Koelink P.J., Breukel C., Salvatori D.C., Jagmohan-Changur S.C., Bosch C.A., Verspaget H.W., Devilee P., Fodde R., Smits R. A new conditional Apc-mutant mouse model for colorectal cancer. Carcinogenesis 2010, 31:946-952.
95. Colnot S., Niwa-Kawakita M., Hamard G., Godard C., Le Plenier S., Houbron C., Romagnolo B., Berrebi D., Giovannini M., Perret C. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab. Investig. J. Tech. Meth. Pathol. 2004, 84:1619-1630.
96. Taketo M.M., Edelmann W. Mouse models of colon cancer. Gastroenterology 2009, 136:780-798.
97. Herrera L., Kakati S., Gibas L., Pietrzak E., Sandberg A.A. Gardner syndrome in a man with an interstitial deletion of 5q. Am. J. Med. Genet. 1986, 25:473-476.
98. Sieber O.M., Lamlum H., Crabtree M.D., Rowan A.J., Barclay E., Lipton L., Hodgson S., Thomas H.J., Neale K., Phillips R.K., Farrington S.M., Dunlop M.G., Mueller H.J., Bisgaard M.L., Bulow S., Fidalgo P., Albuquerque C., Scarano M.I., Bodmer W., Tomlinson I.P., Heinimann K. Whole-gene APC deletions cause classical familial adenomatous polyposis, but not attenuated polyposis or "multiple" colorectal adenomas. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:2954-2958.
99. Cheung A.F., Carter A.M., Kostova K.K., Woodruff J.F., Crowley D., Bronson R.T., Haigis K.M., Jacks T. Complete deletion of Apc results in severe polyposis in mice. Oncogene 2010, 29:1857-1864.
100. Neufeld K.L. Nuclear APC. Adv. Exp. Med. Biol. 2009, 656:13-29.
101. Henderson B.R. Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat. Cell Biol. 2000, 2:653-660.
102. Wang Y., Azuma Y., Moore D., Osheroff N., Neufeld K.L. Interaction between tumor suppressor adenomatous polyposis coli and topoisomerase II{alpha}: implication for the G2/M transition. Mol. Biol. Cell 2008, 19:4076-4085.
103. Jaiswal A.S., Narayan S. A novel function of adenomatous polyposis coli (APC) in regulating DNA repair. Cancer Lett. 2008, 271:272-280.
104. Narayan S., Jaiswal A.S. Activation of adenomatous polyposis coli (APC) gene expression by the DNA-alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine requires p53. J. Biol. Chem. 1997, 272:30619-30622.
105. Zeineldin M., Cunningham J., McGuinness W., Alltizer P., Cowley B., Blanchat B., Xu W., Pinson D., Neufeld K.L. A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression. Oncogene 2011, 31:2423-2437.
106. Lewis A., Davis H., Deheragoda M., Pollard P., Nye E., Jeffery R., Segditsas S., East P., Poulsom R., Stamp G., Wright N., Tomlinson I. The C-terminus of Apc does not influence intestinal adenoma development or progression. J. Pathol. 2012, 226:73-83.
107. Li Q., Ishikawa T.O., Oshima M., Taketo M.M. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis. Cancer Res. 2005, 65:8622-8627.
108. Ishikawa T.O., Tamai Y., Li Q., Oshima M., Taketo M.M. Requirement for tumor suppressor Apc in the morphogenesis of anterior and ventral mouse embryo. Dev. Biol. 2003, 253:230-246.
109. Su L.K., Johnson K.A., Smith K.J., Hill D.E., Vogelstein B., Kinzler K.W. Association between wild type and mutant APC gene products. Cancer Res. 1993, 53:2728-2731.
110. Sansom O. Tissue-specific tumour suppression by APC. Adv. Exp. Med. Biol. 2009, 656:107-118.
111. Gounari F., Chang R., Cowan J., Guo Z., Dose M., Gounaris E., Khazaie K. Loss of adenomatous polyposis coli gene function disrupts thymic development. Nat. Immunol. 2005, 6:800-809.
112. Khazaie K., Zadeh M., Khan M.W., Bere P., Gounari F., Dennis K., Blatner N.R., Owen J.L., Klaenhammer T.R., Mohamadzadeh M. Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:10462-10467.
113. Wilson T.J., Kola I. The LoxP/CRE system and genome modification. Methods Mol. Biol. 2001, 158:83-94.
114. Andreu P., Colnot S., Godard C., Gad S., Chafey P., Niwa-Kawakita M., Laurent-Puig P., Kahn A., Robine S., Perret C., Romagnolo B. Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine. Development 2005, 132:1443-1451.
115. Diegel C.R., Cho K.R., El-Naggar A.K., Williams B.O., Lindvall C. Mammalian target of rapamycin-dependent acinar cell neoplasia after inactivation of Apc and Pten in the mouse salivary gland: implications for human acinic cell carcinoma. Cancer Res. 2010, 70:9143-9152.
116. Fischer J.M., Miller A.J., Shibata D., Liskay R.M. Different phenotypic consequences of simultaneous versus stepwise Apc loss. Oncogene 2012, 31:2028-2038.
117. Holmen S.L., Zylstra C.R., Mukherjee A., Sigler R.E., Faugere M.C., Bouxsein M.L., Deng L., Clemens T.L., Williams B.O. Essential role of beta-catenin in postnatal bone acquisition. J. Biol. Chem. 2005, 280:21162-21168.
118. Hung K.E., Maricevich M.A., Richard L.G., Chen W.Y., Richardson M.P., Kunin A., Bronson R.T., Mahmood U., Kucherlapati R. Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1565-1570.
119. Kuraguchi M., Ohene-Baah N.Y., Sonkin D., Bronson R.T., Kucherlapati R. Genetic mechanisms in Apc-mediated mammary tumorigenesis. PLoS Genet. 2009, 5:e1000367.
120. Lorenz A., Deutschmann M., Ahlfeld J., Prix C., Koch A., Smits R., Fodde R., Kretzschmar H.A., Schuller U. Severe alterations of cerebellar cortical development after constitutive activation of Wnt signaling in granule neuron precursors. Mol. Cell. Biol. 2011, 31:3326-3338.
121. Luis T.C., Naber B.A., Roozen P.P., Brugman M.H., de Haas E.F., Ghazvini M., Fibbe W.E., van Dongen J.J., Fodde R., Staal F.J. Canonical Wnt signaling regulates hematopoiesis in a dosage-dependent fashion. Cell Stem Cell 2011, 9:345-356.
122. Miclea R.L., Karperien M., Bosch C.A., van der Horst G., van der Valk M.A., Kobayashi T., Kronenberg H.M., Rawadi G., Akcakaya P., Lowik C.W., Fodde R., Wit J.M., Robanus-Maandag E.C. Adenomatous polyposis coli-mediated control of beta-catenin is essential for both chondrogenic and osteogenic differentiation of skeletal precursors. BMC Dev. Biol. 2009, 9:26.
123. Qian C.N., Knol J., Igarashi P., Lin F., Zylstra U., Teh B.T., Williams B.O. Cystic renal neoplasia following conditional inactivation of Apc in mouse renal tubular epithelium. J. Biol. Chem. 2005, 280:3938-3945.
124. Qian Z., Chen L., Fernald A.A., Williams B.O., Le Beau M.M. A critical role for Apc in hematopoietic stem and progenitor cell survival. J. Exp. Med. 2008, 205:2163-2175.
125. Sansom O.J., Griffiths D.F., Reed K.R., Winton D.J., Clarke A.R. Apc deficiency predisposes to renal carcinoma in the mouse. Oncogene 2005, 24:8205-8210.
126. Sansom O.J., Reed K.R., Hayes A.J., Ireland H., Brinkmann H., Newton I.P., Batlle E., Simon-Assmann P., Clevers H., Nathke I.S., Clarke A.R., Winton D.J. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev. 2004, 18:1385-1390.
127. Tanwar P.S., Zhang L., Roberts D.J., Teixeira J.M. Stromal deletion of the APC tumor suppressor in mice triggers development of endometrial cancer. Cancer Res. 2011, 71:1584-1596.
128. Wang Y., Jia Y., Franken P., Smits R., Ewing P.C., Lydon J.P., DeMayo F.J., Burger C.W., Anton Grootegoed J., Fodde R., Blok L.J. Loss of APC function in mesenchymal cells surrounding the Mullerian duct leads to myometrial defects in adult mice. Mol. Cell. Endocrinol. 2011, 341:48-54.
129. Hinoi T., Akyol A., Theisen B.K., Ferguson D.O., Greenson J.K., Williams B.O., Cho K.R., Fearon E.R. Mouse model of colonic adenoma- carcinoma progression based on somatic Apc inactivation. Cancer Res. 2007, 67:9721-9730.
130. Akyol A., Hinoi T., Feng Y., Bommer G.T., Glaser T.M., Fearon E.R. Generating somatic mosaicism with a Cre recombinase-microsatellite sequence transgene. Nat. Methods 2008, 5:231-233.
131. Amos-Landgraf J.M., Kwong L.N., Kendziorski C.M., Reichelderfer M., Torrealba J., Weichert J., Haag J.D., Chen K.S., Waller J.L., Gould M.N., Dove W.F. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:4036-4041.
132. Cooper H.S., Chang W.C., Coudry R., Gary M.A., Everley L., Spittle C.S., Wang H., Litwin S., Clapper M.L. Generation of a unique strain of multiple intestinal neoplasia (Apc(+/Min-FCCC)) mice with significantly increased numbers of colorectal adenomas. Mol. Carcinog. 2005, 44:31-41.
133. Jackson-Thompson J., Ahmed F., German R.R., Lai S.M., Friedman C. Descriptive epidemiology of colorectal cancer in the United States, 1998-2001. Cancer 2006, 107:1103-1111.
134. Trainer A.H. Extra-colonic manifestations of familial adenomatous polyposis coli. Adv. Exp. Med. Biol. 2009, 656:119-127.
135. Yoshimi K., Tanaka T., Takizawa A., Kato M., Hirabayashi M., Mashimo T., Serikawa T., Kuramoto T. Enhanced colitis-associated colon carcinogenesis in a novel Apc mutant rat. Cancer Sci. 2009, 100:2022-2027.